Clinical
RSSArticles
-
Combination of Simvastatin Plus Vitamin D Offers New Hope for Migraine Prevention
Recent study shows the combination of simvastatin plus vitamin D3 is effective in the prevention of headaches in adults with episodic migraine.
-
Preventing 90% of Stroke with 10 Modifiable Risk Factors
Controlling 10 modifiable risk factors would prevent 90.7% of strokes, according to results from a 32-country study.
-
Reducing Cardiovascular Events in Older Adults Through Blood Pressure Control
Among ambulatory adults ≥ 75 years of age, treating to a systolic blood pressure (SBP) target of < 120 mmHg compared with an SBP target of < 140 mmHg resulted in a significantly lower rate of fatal and nonfatal major cardiovascular events and death from any cause.
-
Predicting Opioid Abuse and Dependence
It is critical to learn how to better identify patients at risk of opioid addiction, abuse, and dependence.
-
Updates on the USPSTF Colorectal Cancer Screening Recommendations
In accordance with previous recommendations, the United States Preventive Services Task Force still endorses colorectal cancer screening in adults 50-75 years of age.
-
SPRINT: Celebrating Benefits for Older Patients
Using available knowledge, age should not be considered a barrier to seeking good blood pressure control.
-
Many Treatment Choices for Type 2 Diabetes
Despite an impressive amount of data, no particular class of agents — as monotherapy or in combination — provided distinct advantages for risk reduction of cardiovascular events or mortality.
-
Ticagrelor vs. Aspirin in Post-TIA and Stroke Patients
Aspirin should remain the drug of choice, except for patients who are aspirin-intolerant.
-
Antiretroviral Therapy for HIV Patients
Would it be safe for serodiscordant couples to omit barrier methods entirely?
-
FDA Approves Lixisenatide for Type 2 Diabetes
The FDA approved lixisenatide (Adlyxin), a once-daily injection, to improve blood sugar in adults with type 2 diabetes.